Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation

Autor: Lihui Cao, Joyce Neumann, Laura K. Whited, Haley E. Gale-Capps, Terri Lynn Shigle, Uday R. Popat, Rachel Ombres, An Ngo-Huang, Tacara Soones, Zandra R. Rivera, Hilary Barelas Sullivan, Rhodora C. Fontillas, Brent Braveman, Brittany C. Kurse, Jill K. Ferguson, David Marin, Richard Lindsay, Nicholas A. Szewczyk, Alison M. Gulbis, Elizabeth J. Shpall, Whitney Wallis, Richard E. Champlin, Latoya Adekoya
Rok vydání: 2021
Předmět:
Zdroj: Transplantation and cellular therapy. 27(12)
ISSN: 2666-6367
Popis: Increasingly, patients age ≥65 years are undergoing allogeneic hematopoietic stem cell transplantation (allo-SCT). Although age alone is a well-documented predictor of overall survival (OS) and nonrelapse mortality (NRM), growing evidence suggests that poor functional status and frailty associated with aging may have roles as well. Our goal in the present study was to identify and improve these and other aging-related maladies by developing a multimodal supportive care program for older allo-SCT recipients. We designed and implemented a multimodal supportive care program, Enhanced Recovery in Stem Cell Transplant (ER-SCT), for patients age ≥65 years undergoing allo-SCT. The ER-SCT program consists of evaluation and critical interventions by key health care providers from multiple disciplines starting before hospital admission for transplantation and extending through 100 days post-allo-SCT. We determined the feasibility of implementing this program in a large stem cell transplantation center. After 1 year of ongoing process improvements, multiple evaluations, and enrollment, we found that a dedicated weekly clinic was necessary to coordinate care and evaluate patients early. We successfully enrolled 57 of 64 eligible patients (89%) in the first year. Our data show that a multimodal supportive care program to enhance recovery for older patients undergoing allo-SCT is feasible. © 2021 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
Databáze: OpenAIRE
načítá se...